Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $23.6800 (-2.71%) ($23.5200 - $24.6700) on Wed. Jan. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.8% (three month average) | RSI | 26 | Latest Price | $23.6800(-2.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -5.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.9% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.9% (StdDev 3.8%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
1 - 5 Day Possible Target | $13.61(-42.53%) | Resistance Level | $27.02 | 5 Day Moving Average | $25.4(-6.77%) | 10 Day Moving Average | $25.76(-8.07%) | 20 Day Moving Average | $27.02(-12.36%) | To recent high | -19.5% | To recent low | 29.8% | Market Cap | $3.468b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |